XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona announces a comprehensive restage of its Implant business

Dentsply Sirona announces a comprehensive restage of its Implant business

  • With a digital base, historical product strength and signature workflows supported by ongoing education and training, Dentsply Sirona is launching DS Implants, harmonizing successful brands like Simplant, OSSIX, Atlantis and MIS.

  • Three completely connected, seamless signature workflows will take full advantage of digital dentistry for excellent outcomes and patient satisfaction.
  • DS Implants presents DS PrimeTaper, a self-tapping implant with a tapered design that can be inserted safely and easily with a unique double thread, enabling long-term bone stability.

CHARLOTTE, N.C., Sept. 23, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) introduces a comprehensive restage of its Implants business, including three signature workflows to provide dental professionals with a completely new way of practicing implantology and solutions from scan to crown that outperform expectations in efficiency, accuracy, esthetics, longevity and simplicity.

  • The Single Tooth Signature Workflow enables customers to do more and better, faster, simpler, freeing up time to see more patients.
  • The Partial Multiple Tooth Replacement Signature Workflow for more confidence for the clinician and more comfort for the patient.
  • The Full Arch Signature Workflow addresses a signature patient case with an edentulous maxilla.

With a complete ecoystem of digital solutions and products Dentsply Sirona is streamlining implant treatments for practice growth and consistent patient satisfaction. 

Comfort with new products based on well-known procedures

Additionally, Dentsply Sirona Implants presents DS PrimeTaper, a self-tapping implant with a tapered design that can be inserted safely and easily with a unique double thread, enabling long-term bone stability. Dentsply Sirona worked closely with the global implant key opinion leader community, and they have already started gaining experience with the product. Their reactions have been very positive:

Dr. Dan Butterman, dentist from Centennial, Colorado (USA), emphasizes the importance of a seamless workflow. “DS PrimeTaper represents the next step in implant dentistry. The digital-driven workflow results in higher accuracy, repeatability of processes, and time savings.” Butterman adds, "My patients have better things to do than spending time in my office. Thanks to clearly defined processes and digital solutions, I can offer safer and faster treatment options which my patients appreciate. That's what efficiency is all about!"

Seamless concept for transforming digital implant dentistry

“Dentsply Sirona is about intelligent concepts that work intuitively and improve the predictability of treatment,” said Dr. Terri Dolan, Chief Clinical Officer at Dentsply Sirona. “Our goal is to enable clinicians, including both specialists and general practitioners, to focus on what they do best – creating healthy and beautiful smiles. Our vision for digital implant dentistry will be supported by a global clinical education program focused on end-to-end digital implant workflow solutions to achieve clinic, technical and practice excellence. The extensive curriculum is designed to build clinicians’ digital implant skills according to their level of experience and personal learning preferences. These include online education and personalized learning, as well as more than 50 state-of-the art Dentsply Sirona Academy education centers around the world.”

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

Andrea Daley

VP, Investor Relations





EN
24/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE

Dentsply Sirona Reports Second Quarter 2025 Results

Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impactGAAP gross margin of 52.4%, GAAP net loss per share of ($0.22)Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52Executed $550 million debt offeringReaffirmed FY25 outlookLeadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Si...

 PRESS RELEASE

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the “Board”), has been appointed President and Chief Executive Officer, effective A...

 PRESS RELEASE

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Dentsply Sirona to Host Second Quarter Conference Call on August 7th CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website at prior to t...

 PRESS RELEASE

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions. The notes will bear interest at a fixed rate of 8.375% per year until September 12, 2030 (the “First Reset Date”). On and after the Fi...

Moody's Ratings assigns Baa3 rating to Dentsply Sirona's proposed hybr...

Moody's Ratings (Moody's) assigned a Baa3 rating to Dentsply Sirona Inc.'s ("Dentsply Sirona") proposed offering of junior subordinated notes ("hybrid"). At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch